CMED: The 'Curupira' of Brazil's Pharma Market.
- Resource Type
- Article
- Authors
- Alencar, Rafael; Torgal, Mariana; Pinheiro, Catarina Costa
- Source
- Pharmaceutical Executive; Feb2017, Vol. 37 Issue 2, p24-25, 2p
- Subject
- PHARMACEUTICAL industry
MARKETING strategy
DRUG prices
PRICE regulation
MEDICINE
MARKETING
- Language
- ISSN
- 02796570
The article offers information on the Câmara de Regulação do Mercado de Medicamentos (CMED) which is the regulatory chamber of the medicine market in Brazil. It outlines several factors that drives CMED pricing outcomes and mentions that innovative drugs with a patent may achieve Category I and II of CMED. It notes that CMED has not set the price for any innovative drug studied at the level of generic comparators.